share_log

圣达生物(603079.SH)申请向特定对象发行股票获上交所审核通过

Zhejiang Shengda Bio-Pharm (603079.SH) has successfully passed the Shanghai Stock Exchange's review for the issuance of stocks to specific individuals.

Zhitong Finance ·  Nov 22 19:00

zhejiang shengda bio-pharm (603079.SH) issued an announcement, recently received a notice from the Shanghai Stock Exchange Listing Review Center...

According to the announcement by Financial Associated Press, zhejiang shengda bio-pharm (603079.SH) recently received a notice from the Shanghai Stock Exchange Listing Review Center regarding the approval of the issuance of stocks to specific entities. Based on the review results, the company's application to issue stocks to specific entities complies with the issuance conditions, listing conditions, and information disclosure requirements.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment